Search

Robinson, Christopher, Xiaohong Zhou, Jaya Rajaiya, Mohammad Yousuf, Gurdeep Singh, Joshua DeSerres, Michael Walsh, et al. 2013. “Predicting the Next Eye Pathogen: Analysis of a Novel Adenovirus”. MBio 4 (2): e00595-12.

Spurr-Michaud, Sandra, and Ilene Gipson. 2013. “Methods for Culture of Human Corneal and Conjunctival Epithelia”. Methods Mol Biol 945: 31-43.

Sugi, Norito, Emily Whiston, Bruce Ksander, and Meredith Gregory. 2013. “Increased Resistance to Staphylococcus Aureus Endophthalmitis in BALB/C Mice: Fas Ligand Is Required for Resolution of Inflammation But Not for Bacterial Clearance”. Infect Immun 81 (6): 2217-25.

VanderVeen, Deborah, Camilia Martin, Reshma Mehendale, Elizabeth Allred, Olaf Dammann, Alan Leviton, and ELGAN Study Investigators. 2013. “Early Nutrition and Weight Gain in Preterm Newborns and the Risk of Retinopathy of Prematurity”. PLoS One 8 (5): e64325.

Walshe, Tony, Nathaniel Dela Paz, and Patricia D’Amore. 2013. “The Role of Shear-Induced Transforming Growth Factor-β Signaling in the Endothelium”. Arterioscler Thromb Vasc Biol 33 (11): 2608-17.

Wiggs, Howell, Linkroum, Abdrabou, Hodges, Braine, L. R. Pasquale, GJ Hannon, Haines, and John. 2013. “Variations in COL15A1 and COL18A1 Influence Age of Onset of Primary Open Angle Glaucoma”. Clin Genet 84 (2): 167-74.

Woodward, Mauris, and Argüeso. 2013. “Binding of Transmembrane Mucins to Galectin-3 Limits Herpesvirus 1 Infection of Human Corneal Keratinocytes”. J Virol 87 (10): 5841-7.

Yoon, Michael, Frederick Jakobiec, and Pia Mendoza. 2013. “Canaliculops: Clinicopathologic Features and Treatment With Marsupialization”. Am J Ophthalmol 156 (5): 1062-1068.e1.

Ziaei, Alireza, Thore Schmedt, Yuming Chen, and Ula Jurkunas. 2013. “Sulforaphane Decreases Endothelial Cell Apoptosis in Fuchs Endothelial Corneal Dystrophy: A Novel Treatment”. Invest Ophthalmol Vis Sci 54 (10): 6724-34.

Amparo, Francisco, Mohammad Dastjerdi, Andre Okanobo, Giulio Ferrari, Leila Smaga, Pedram Hamrah, Ula Jurkunas, Debra Schaumberg, and Reza Dana. 2013. “Topical Interleukin 1 Receptor Antagonist for Treatment of Dry Eye Disease: A Randomized Clinical Trial”. JAMA Ophthalmol 131 (6): 715-23.